Thermo Fisher Scientific Inc
- 取引所
- 米国株
- 国 / 地域
- USA
- 上場日
- 1978年1月13日
- 従業員数
- 125,000
- 公式サイト
- www.thermofisher.com
総合バリュエーションレンジ · 保守的 $340–$385 / 妥当 $440–$495 / 楽観的 $545–$615。$559.53 時点で 楽観的な本源的価値レンジ内 · 多くの期待を織り込み済み。
レポート公開時 $448.28（2026年5月25日）
データ提供：EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
沿革
Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts, with an IPO date of January 13, 1978. Under its "serving science" mission, the company grew through long-term acquisition integration led by CEO Marc Casper, who has held the role since 2009. It now operates through four segments—Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services—and employs about 125,000 people across a portfolio of brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD.
業界での地位
Thermo Fisher provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services to pharmaceutical and biotech firms, academic and government research institutions, hospitals, clinical labs, and industrial and environmental customers in North America, Europe, Asia-Pacific, and internationally. In 2025 it generated revenue of USD 44.556 billion. Its competitors include Danaher (2025 sales about USD 24.568 billion), Agilent (fiscal 2025 net revenue about USD 6.948 billion), and Waters (2025 net sales about USD 3.165 billion).
この銘柄のレポートはお使いの言語でまだありません。